Dr. Anton Poterajlo

Claim this profile

Accellacare

Studies Arthritis
Studies Rheumatoid Arthritis
4 reported clinical trials
10 drugs studied

Clinical Trials Anton Poterajlo is currently running

More about Anton Poterajlo

Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Anton Poterajlo has experience with
  • EDP-305
  • Placebo
  • Qutenza (capsaicin) 8% Topical System
  • Capsaicin 0.04% Topical System
  • GSK3196165 (Otilimab)
  • Tofacitinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anton Poterajlo specialize in?
Anton Poterajlo focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Anton Poterajlo currently recruiting for clinical trials?
Yes, Anton Poterajlo is currently recruiting for 1 clinical trial in Kenilworth Warwickshire. If you're interested in participating, you should apply.
Are there any treatments that Anton Poterajlo has studied deeply?
Yes, Anton Poterajlo has studied treatments such as EDP-305, Placebo, Qutenza (capsaicin) 8% topical system.
What is the best way to schedule an appointment with Anton Poterajlo?
Apply for one of the trials that Anton Poterajlo is conducting.
What is the office address of Anton Poterajlo?
The office of Anton Poterajlo is located at: GSK Investigational Site, Kenilworth, Warwickshire CV8 1JD United Kingdom. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.